MISSION® esiRNA
SIGMA/EHU085781 - targeting human ATG5
Product Type: Product-on-demand
| description | Powered by Eupheria Biotech |
| Ensembl | human accession no. | ENSG00000057663 ![]() |
| esiRNA cDNA target sequence | CAGATGGACAGTTGCACACACTAGG |
| form | lyophilized powder |
| NCBI accession no. | NM_004849 ![]() |
| product line | MISSION® |
| Quality Level | 100 ![]() |
| shipped in | ambient |
| storage temp. | −20°C |
| Biochem/physiol Actions: | ATG5 (autophagy protein 5) is involved in the formation of autophagosomes. It is part of the E3-like ATG12-ATG5-ATG16 complex, which is involved with autophagic vesicle formation and expansion. ATG5 is also needed for antigen presentation and thereby enhances viral clearance. Mutation in this gene decreases autophagy, thereby causing ataxia with developmental delay. The ATG5 gene is upregulated in systemic lupus erythematosus. It is also associated with Behçet′s disease. Polymorphisms in this gene are linked with neutrophilic airway inflammation, particularly in adult asthma. |
| General description: | MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing. For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA . |
| Legal Information: | MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany |
| RIDADR | NONH for all modes of transport |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 41105324 |

